Apheris Raises €20.1 Million to Revolutionize Data Collaboration in Life Sciences
Apheris, a leading federated computing company specializing in secure data collaboration for the life sciences sector, has successfully raised €20.1 million in a Series A funding round. The investment was co-led by prominent European DeepTech venture capital firms OTB Ventures and eCAPITAL, with continued support from existing investors Octopus Ventures and Heal Capital.
Founded in 2019 by CEO Robin Röhm and CTO Michael Hoh, Apheris addresses the critical challenge of enabling secure and private data collaboration among pharmaceutical companies, healthcare institutions, and research organizations. Their platform allows for advanced analytics and artificial intelligence applications on decentralized datasets without compromising data privacy or intellectual property.
The newly secured funds will be utilized to expand Apheris’ reach as the preferred federated computing provider for leading biopharmaceutical organizations. This includes enhancing their platform’s capabilities, scaling operations, and fostering partnerships that drive innovation in drug discovery and personalized medicine.
“I’m very excited to welcome OTB Ventures and eCAPITAL as new partners on our journey,” said CEO Robin Röhm. “Their deep understanding of the complexities of building a high-security, technically advanced product stood out. With their help, Apheris will unlock the potential of AI and machine learning for the life science industry by solving its critical bottleneck: access to large and diverse data.”
Marcin Hejka, Co-Founder and General Partner at OTB Ventures, expressed confidence in Apheris’ vision: “We are thrilled to partner with Apheris as the lead investor in this equity round. Apheris is pioneering the future of distributed data infrastructure, enabling organizations to unlock the full potential of their AI/ML workloads while keeping sensitive raw data secure and local.”
Hannes Schill, Managing Partner at eCAPITAL, highlighted the importance of secure data collaboration: “We have closely followed Apheris’ journey since its inception and have been impressed by their technological advancements in federated computing. As cybersecurity investors, we recognize the growing importance of secure and private data collaboration, particularly in the life sciences sector where such capabilities can drive transformative outcomes.”
With this investment, Apheris is poised to become a leading force in transforming how life sciences organizations collaborate on sensitive data, driving advancements that have the potential to significantly impact global health outcomes.
